A Mix Up That Is Inexcusable- Pradaxa & Plavix Mix-up In Canada

What would you do if you found out that harm was caused to you or a loved one because someone mixed up your medications, just because the names apparently sound familiar to some?  I know I would be livid, and seeking some sort of justice.  But me seeking justice, is not the point of this article.

Apparently, Health Canada is warning consumers that two prescription drugs, Pradax, also known as Pradaxa here in the US, and Plavix, are involved in a drug mix-up in Canada, because the names sound alike.

Sounds like a lame excuse to cover up an error if you ask me!!

The drug makers, Boehringer Ingelheim (Canada) Ltd., Sanofi-Aventis Canada Inc., and Health Canada just issued a warning advising patients of the risk of medication errors connecting the 2 medications, Pradax (dabigatran) and Plavix (clopidogrel), said CBC News.

But, what are the differences in the 2 drugs?

Pradaxa is a blood thinner prescribed to patients who have an atrial fibrillation and is one of a number of new anti-blood-clotting pills expected to replace warfarin.  CBC News pointed out that Pradaxa is often used after hip or knee replacement surgery to prevent blood clots.  This has also recently became a highly controversial drug, as you can see in some of our recent articles, Death Toll Reaches At Least 50, and Drug Given Approval Too Quickly.

Plavix helps keep platelets in the blood from sticking together and forming clots that could lead to heart attack or stroke, Health Canada said. Plavix can be prescribed in combination with ASA to patients with irregular heartbeat who cannot take blood thinners.  Plavix, on the other hand has also been linked to some severe side effects, such as, a life-threatening blood disorder in some users known as thrombotic thrombocytopenic purpura, or TTP. TTP is marked by the formation of blood clots in small blood vessels throughout the body. Untreated, TTP blood clots block the blood vessels and limit blood flow to the brain, kidneys, or heart.

According to the news article, since January, a total of five Canadian cases involving drug name mix-ups between Pradax and Plavix have been reported, including one patient who had non-serious bleeding after a medical procedure.

There have also been two reports of concerns raised by health care professionals about potential for confusion because the names of the two drugs are similar.

Receiving Pradax instead of Plavix or vice versa may result in harm, including increased risk of bleeding, stroke, heart attack or blood clots, Health Canada said.

Health Canada is now encouraging patients to be aware of the names and uses of all the medications they take and to carry a list of their current medications, providing it to physicians, dentists, or pharmacists if admitted to a hospital, wrote CBC News.

Also in order to prevent medication errors, patients should be certain they can read the name of their medications on written prescriptions; if not, have the doctor print the drug’s name on the prescription.  Patients should also be clear as to why they are receiving their mediations and the properties and appearance of the medications they take. Customers are also encouraged to read their medications’ patient leaflets and refer questions to their doctor or druggist.

Although as consumers we should definitely be aware and pay special attention to our medications, as stated, this is simply an inexcusable error.  And I believe could be avoided altogether, if the medical professionals administering the drugs simply paid special attention to details.



, , , ,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Underground Railway Dust May Pose Health Risk

Travelling or working on an underground railway for sustained period of time could have health implications due to concentrations of metal-rich microscopic dust particles.

New Study Helps Understand Why Health Care Costs On The Rise

Although many believe is it medical malpractice suites that are causing the increase in the health care costs, it is actually the fear of them that is partly to blame. Doctors are ordering unnecessary tests and procedures for fear of a patient filing a claim down the road

FDA Issues New Warnings Concerning Tolvaptan

The FDA has issued a drug safety communication concerning Tolvaptan, a selective vasopression V2-receptor antagonist used in heart failure patients to treat clinically significant hypervolemic and euvolemic hyponatremia.

New Antiepileptic Drug Causes Blue Discoloration And Vision Trouble

An antiepileptic drug to hit the market has been known to cause vision troubles and skin discoloration. Almost all patients experienced gray/blue skin discoloration who had been taking the pill for two years. More information is needed to better understand the occurrences.

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

Latest Medical Device Injury News

Women 30% More Likely To Need Repeat Hip Implant Surgery

Doctors traditionally believed the larger the size of the implant, the more protective it was against failure, according to Sedrakyan. However, he said his study found regardless of size, women had a higher rate of revision occurrence, so some other factor besides the actual implants may be leading to this effect.

Transvaginal Mesh Lawsuits – Who Is At Fault?

For some women a pelvic transvaginal mesh product has been a god sent.  To be able to resume a full active life, without the worry of a leaky bladder, is a true miracle for some women.  And, this only became possible with the help of pelvic mesh. The mesh is most commonly used after pelvic [...]

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]